Document is current

Article History

Received: 14 August 2020

Accepted: 15 February 2021

First Online: 22 March 2021

Declarations

:

: At the time of writing, this trial has been approved by the Research Ethics Board of Unity Health Toronto (CTO Project ID #2126). Written informed consent must be provided by each study participant, or their parent/legal guardian in the case of incapable minors.

: Not applicable.

: DHST has received investigator-initiated research grants to his institution from Gilead and Viiv Healthcare. DHST is a Site Principal Investigator for clinical trials sponsored by Glaxo Smith Kline. PJ serves as an unpaid member of the steering group or executive committee of trials funded by Abbott Vascular, Astra Zeneca, Biotronik, Biosensors, St. Jude Medical, Terumo, and The Medicines Company, has received research grants to the institution from Appili Therapeutics, Astra Zeneca, Biotronik, Biosensors International, Eli Lilly, The Medicines Company, and honoraria to the institution for participation in advisory boards and/or consulting from Amgen, Ava, and Fresenius, but has not received personal payments by any pharmaceutical company or device manufacturer. SLW serves on advisory boards, speaks at continuing medical education events and conducts clinical trials through her institution with Gilead, Merck, Viiv Healthcare, and Jansen.